comprehensive -WSS

comprehensive

author：fashion 2025-08-28 02:51:15 - browse：39

Richard Neal(D-MA), Rep. Frank Pallone (D-NJ),Rep. John Yarmuth (D-KY), Rep. Bobby Scott (D-VA) and House Minority Leader Nancy Pelosi (D-CA) attend the weekly press conference in the Capitol building on July 20, 2017 in Washington, DC. They spoke to the media about the efforts to reform the health care bill. -- health policy coverage from STAT — Reps. Richard Neal (D-Mass.), Rep. Frank Pallone (D-N.J.), and Rep. John Yarmuth (D-Ky.) Joe Raedle/Getty Images

WASHINGTON — It’s drug pricing déjà vu: Just as they did in 2019, House Democrats are pushing a bill that would allow Medicare to negotiate dozens of drug prices a year, offer those prices to all insurers, and crack down on price hikes.

Unlike then, Democrats have a starting place: the new bill represents an expansion of the major drug pricing legislation the party passed last year. But the first round of drug price negotiations hasn’t even started yet, and the law is under attack from the pharmaceutical industry in court.

The Democratic leaders of three key House committees put forth the proposal Wednesday.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： STAT Summit: Michael J. Fox on progress in Parkinson's research

knowledge

WSS

UnitedHealth’s board chair also owns a personal investment firm

Readout LOUD: Venture capital, Gilead, and more M&A

Top private equity targets in 2023: cardiology, clinical trials, lasers

UnitedHealth’s board chair also owns a personal investment firm

AI gets buy

The Biogen Aduhelm mess could happen again

hotspot

comprehensive

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

Why Novartis is going to walk from its acquisition of MorphoSys

Medicare proposal to cover medical devices draws a mixed reaction

The EU Joint Clinical Assessment needs to live up to its promise

Affirmative action in medical school literally saved lives

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

United colonoscopy coverage change 'may cost lives,' doctors say

A single Democrat is willing to weaken Medicare negotiation power

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The explosion of genetic testing requires a new approach

knowledge

Will Ozempic

Senate committee scrutinizes Medicare Advantage brokers

STAT Readout Newsletter: Today's biggest biotech updates

FDA gives detailed accounting of AI

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Why Novartis is going to walk from its acquisition of MorphoSys

hotspot

Wikipedia

knowledge

knowledge